Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Chimerix Inc (NQ: CMRX )

1.310 +0.030 (+2.34%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 21, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 410,653
Open 1.300
Bid (Size) 1.300 (2)
Ask (Size) 1.320 (1)
Prev. Close 1.280
Today's Range 1.292 - 1.320
52wk Range 1.270 - 5.390
Shares Outstanding 86,249,744
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank
The collapse of SVB Financial Group (NASDAQ: SIVB) could have a ripple effect on the technology and biotech industries, the two largest sectors that had deposits and financial relationships with the... 
Via Benzinga
Sunrun Down Over 10% On Silicon Valley Bank Exposure: What Other Companies Are Exposed?
Shares of Sunrun Inc (NASDAQ: RUN), the largest residential solar developer in the U.S, fell by as much as 15% on Friday as a result of the news that Silicon Valley Bank has been closed by the 
Via Benzinga

Performance

YTD
-29.95%
-29.95%
1 Month
-16.56%
-16.56%
3 Month
-32.47%
-32.47%
6 Month
-33.84%
-33.84%
1 Year
-74.31%
-74.31%

More News

Read More
Looking Into Chimerix's Return On Capital Employed
Via Benzinga
The Top 7 Growth Stocks in Biotech
Via InvestorPlace
Chimerix's Earnings Outlook
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Chimerix Reports Fourth Quarter and Year End 2022 Financial Results and Provides Operational Update
From Chimerix, Inc.
Via Globe NewsWire
Chimerix to Present at Cowen and Company 43rd Annual Health Care Conference
From Chimerix, Inc.
Via Globe NewsWire
Chimerix to Report Fourth Quarter and Year End 2022 Financial Results and Provide an Operational Update on March 2, 2023
From Chimerix, Inc.
Via Globe NewsWire
7 Overlooked Value Stocks That Could Outperform the Market
Via InvestorPlace
The 7 Best Biotech Stocks to Buy for February 2023
Via InvestorPlace
The 7 Most Undervalued Biotech Stocks to Buy in February 2023
Via InvestorPlace
Chimerix to Present at 41st Annual J.P. Morgan Healthcare Conference
From Chimerix, Inc.
Via Globe NewsWire
Chimerix Announces Successful Launch of ONC201 Phase 3 ACTION Study at Society for Neuro-Oncology Conference and Provides Operational Update
From Chimerix, Inc.
Via Globe NewsWire
Chimerix Responds to Rubric Capital Management
From Chimerix, Inc.
Via Globe NewsWire
Rubric Capital Management Sends Letter to Chimerix Board of Directors
From Rubric Capital Management LP
Via Business Wire
Threats For New Outbreak Looms, As Scientists Signal Deadly Monkeypox Variant Circulating In Central Africa
Via Benzinga
Chimerix: Q3 Earnings Insights
Via Benzinga
Why Etsy Shares Are Trading Sharply Higher; Here Are 31 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Chimerix Reports Third Quarter 2022 Financial Results and Provides Operational Update
From Chimerix, Inc.
Via Globe NewsWire
Chimerix's Earnings: A Preview
Via Benzinga
Chimerix to Report Third Quarter 2022 Financial Results and Provide an Operational Update on November 3, 2022
From Chimerix, Inc.
Via Globe NewsWire
$1.2 Million Bet On ChromaDex? Check Out These 4 Penny Stocks Insiders Are Buying
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.